ARVYS Proteins
Private Company
Total funding raised: $5M
Overview
ARVYS Proteins is a specialized CRO providing end-to-end custom protein services, from gene synthesis and expression to purification, characterization, and functional assay development. The company operates as a fee-for-service provider, catering primarily to the research and early-stage discovery needs of biopharma and academic clients. With a focus on technical expertise, aggressive timelines, and confidentiality, ARVYS positions itself as a flexible and high-quality partner in the highly fragmented protein services market. Its business model is based on generating revenue through contracted research services rather than developing its own therapeutic pipeline.
Technology Platform
Integrated suite of protein science capabilities including genetic engineering, multi-host recombinant protein expression (bacterial, yeast, insect, mammalian), purification, characterization, and functional assay development.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
ARVYS competes in a crowded market of protein service CROs, ranging from small boutique labs to large, diversified players like Lonza and Thermo Fisher. Its differentiation hinges on technical expertise, personalized service, and a broad multi-system expression capability, rather than scale or brand recognition.